J&J lifts dividend but cuts guidance as pandemic clouds outlook
Johnson & Johnson is the first of the major US health-care company to report earnings and is viewed as a bellwether for the sector
14 April 2020 - 18:31
New York — Johnson & Johnson (J&J) on Tuesday reined in its outlook for 2020 due to the expected effects of the coronavirus pandemic, becoming the latest company to have to shift gears in the face of the economic shock created by Covid-19.
At the same time, J&J posted stronger sales and earnings for the first quarter compared with a year ago, and boosted its quarterly dividend...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.